What's new

Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya vaccine (live), Date of authorisation: 28/06/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya vaccine (live), Date of authorisation: 28/06/2024, Revision: 1, Status: Authorised

Apr 9, 2025 - 12:47
 0
Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya vaccine (live), Date of authorisation: 28/06/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya vaccine (live), Date of authorisation: 28/06/2024, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Australia regulator waves through Woolworths’ Beak & Johnston deal 

Next Article

New NATO-Ukraine Centre hosts resilience workshop to enhance cooperation and rea...

Related Posts

Human medicines European public assessment report (EPAR): Bortezomib Accord, bortezomib, Date of authorisation: 20/07/2015, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 1, 2025  0

Orphan designation: Humanised IgG4 monoclonal antibody against C1q Treatment of Guillain-Barré syndrome, 10/02/2025 Positive

Orphan designation: Humanised IgG4 monoclonal antibody ...

Mar 12, 2025  0

Procurement

Procurement

Feb 9, 2025  0